Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the

Updated on: January 11,2024

Nirogacestat, a new desmoid tumor treatment, found to improve outcomes for people with sarcoma

byMemorial Sloan Kettering Cancer CenterCredit:New England Journal of Medicine(2023). DOI: 10.1056/NEJMoa2210140When Dana Avellino, now 36, first noticed a lump near her groin in the

Updated on:January 11,2024

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Updated on: October 24,2024

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Updated on:October 24,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on: January 26,2024

Study reports progress in long-term protection against ovarian cancer tumors

byWayne State UniversityCharacterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or

Updated on:January 26,2024

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality

Updated on: December 25,2023

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality

Updated on:December 25,2023

New insight into protein could pave the way for new cancer treatments

FEBRUARY 29, 2024by Anna Björklund, Identification of a conformational switch in c-MYC.aOverview of the MD strategy employed to identify regions that exhibit probe-induced conformational changes

Updated on: March 15,2024

New insight into protein could pave the way for new cancer treatments

FEBRUARY 29, 2024by Anna Björklund, Identification of a conformational switch in c-MYC.aOverview of the MD strategy employed to identify regions that exhibit probe-induced conformational changes

Updated on:March 15,2024

Researchers create new cancer fighting compound

by Elizabeth Chapin,University of KentuckyGraphical abstract. Credit:Chemical Communications(2022). DOI: 10.1039/D2CC03081KA University of Kentucky Markey Cancer Center researcher&#3

Updated on: January 28,2024

Researchers create new cancer fighting compound

by Elizabeth Chapin,University of KentuckyGraphical abstract. Credit:Chemical Communications(2022). DOI: 10.1039/D2CC03081KA University of Kentucky Markey Cancer Center researcher&#3

Updated on:January 28,2024

Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

by Kayla Wiles,Purdue UniversityPurdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel, which has been approved by the FDA for

Updated on: May 11,2024

Treat cancer with cold plasma? Aerospace engineer helps bring first clinical trial

by Kayla Wiles,Purdue UniversityPurdue aerospace engineer Alexey Shashurin assisted in the development of the Canady Helios Cold Plasma System and Scalpel, which has been approved by the FDA for

Updated on:May 11,2024

Lymphoma mutation yields super-competitive immune cells

by Heather Lindsey,Cornell UniversitySupercompetition in germinal centers leads to aggressive B cell lymphomas. GC B cells vigorously compete against each other to receive limiting T cell help,

Updated on: December 28,2023

Lymphoma mutation yields super-competitive immune cells

by Heather Lindsey,Cornell UniversitySupercompetition in germinal centers leads to aggressive B cell lymphomas. GC B cells vigorously compete against each other to receive limiting T cell help,

Updated on:December 28,2023

Researchers develop new CRISPR-based tool for cancer diagnosis

by Leah Buletti,University of FloridaThe one-pot EXTRA-CRISPR miRNA assay. Credit:Nature Biomedical Engineering(2023). DOI: 10.1038/s41551-023-01033-1A team of University of Florida

Updated on: January 30,2024

Researchers develop new CRISPR-based tool for cancer diagnosis

by Leah Buletti,University of FloridaThe one-pot EXTRA-CRISPR miRNA assay. Credit:Nature Biomedical Engineering(2023). DOI: 10.1038/s41551-023-01033-1A team of University of Florida

Updated on:January 30,2024

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Updated on: January 10,2024

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Updated on:January 10,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on: January 04,2024

Dual immunotherapy shows promise to treat recurrent or metastatic nasopharyngeal cancer

by SingHealthDetails on patient response and outcome data.aExtent and depth of response in trial cohort showing best tumor scan (Top) and changes in tumor size over time (Bottom). Not eval

Updated on:January 04,2024

Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

by Mayo ClinicCredit: Unsplash/CC0 Public DomainA new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cel

Updated on: April 06,2024

Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

by Mayo ClinicCredit: Unsplash/CC0 Public DomainA new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cel

Updated on:April 06,2024